惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
T
The Blog of Author Tim Ferriss
博客园 - 司徒正美
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
有赞技术团队
有赞技术团队
量子位
S
SegmentFault 最新的问题
博客园 - 聂微东
博客园 - 【当耐特】
J
Java Code Geeks
美团技术团队
Hugging Face - Blog
Hugging Face - Blog
H
Help Net Security
V
V2EX
人人都是产品经理
人人都是产品经理
博客园 - Franky
罗磊的独立博客
Engineering at Meta
Engineering at Meta
A
About on SuperTechFans
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
酷 壳 – CoolShell
酷 壳 – CoolShell
云风的 BLOG
云风的 BLOG
Y
Y Combinator Blog
Apple Machine Learning Research
Apple Machine Learning Research

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call Trans...
2026-04-23 · via All Articles on Seeking Alpha

Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call April 21, 2026 8:01 PM EDT

Company Participants

Dig Howitt - CEO, MD, President & Executive Director

Conference Call Participants

David Low - UBS Investment Bank, Research Division
Andrew Goodsall - MST Financial Services Pty Limited, Research Division
David Stanton - Jefferies LLC, Research Division
Saul Hadassin - Barrenjoey Markets Pty Limited, Research Division
Chris Cooper - JPMorgan Chase & Co, Research Division
Steven Wheen - Jarden Australia Pty Limited, Research Division
David Bailey - Morgan Stanley, Research Division
Craig Wong-Pan - RBC Capital Markets, Research Division
Sacha Krien - E&P, Research Division
Stuart Welch - Alphinity Investment Management Pty Ltd.
Davinthra Thillainathan - Goldman Sachs Group, Inc., Research Division
Shane Ponraj - Morningstar Inc., Research Division

Presentation

Operator

Thank you for standing by, and welcome to the Cochlear Investor Call. [Operator Instructions]

I would now like to hand the conference over to Mr. Dig Howitt, CEO and President. Please go ahead.

Dig Howitt
CEO, MD, President & Executive Director

Thanks, everyone, for joining on short notice this morning. As I said, we're going to make a few comments to open. What I'd like to do is talk through what are the issues that are impacting the business that have led to a lower sales and lower profit. What are the short-term implications of them for the P&L? And then I think perhaps most importantly, what are the implications for our longer-term strategy and how we implement strategy. So I want to make some comments on each of those, and then we'll open up for questions.

So starting off just with sort of what's happened more recently and what do we see that might be sitting behind that. And I'll start -- talk through each of the segments. I'm going to talk with developed market cochlear implants first and spend most of my time on that